Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03718455 · ClinicalTrials.gov registry record · NA
Evaluation of Magseed as Localization Device for Biopsy Proven Metastatic Axillary Lymph Nodes
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03718455: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT03718455 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03718455, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Currently, breast cancer patients who are treated with neoadjuvant chemotherapy (NAC) before surgery may have a biopsy clip placed in the lymph node at the time of or shortly after percutaneous biopsy. Following 12-20+ weeks of NAC, pre-surgical localization of the sampled axillary lymph node using a radioactive seed can be done up to 5 days prior to surgery. Localization of the sampled lymph node in patients with complete imaging response to NAC can be technically challenging if the biopsy clip is not sonographically visible. This study is designed to see if it is feasible to place a Magseed, which is magnetic seed, into the abnormal node either at the time of fine needle aspiration (FNA) or after NAC, just prior to surgery, and to be able to accurately identify the abnormal node at the time of surgery.
Interventions
- DEVICE Axillary Magseed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-10-30 |
| Est. Completion | 2019-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03718455
The ClinicalTrials.gov registry entry for NCT03718455 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Axillary Magseed is the first listed.
NCT03718455 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03718455 about?
NCT03718455 is a clinical study titled "Evaluation of Magseed as Localization Device for Biopsy Proven Metastatic Axillary Lymph Nodes". Currently, breast cancer patients who are treated with neoadjuvant chemotherapy (NAC) before surgery may have a biopsy clip placed in the lymph node at the time of or shortly after percutaneous biopsy. Following 12-20+ weeks of NAC, pre-surgical localization of the sampled axillary lymph node using ...
What is the current status of trial NCT03718455?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2018-10-30. Estimated completion is 2019-12-01.
What interventions are being tested in trial NCT03718455?
The interventions under investigation include: Axillary Magseed (DEVICE).
Who is sponsoring clinical trial NCT03718455?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.